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Introduction
Chloride is the major strong anion in blood – accounting 
for approximately one-third of plasma tonicity, for 97 to 
98% of all strong anionic charges and for two-thirds of all 
negative charges in plasma [1]. Th e amount of attention 
chloride receives in critically ill patients, however, is 
limited and much less than other routinely measured 
electrolytes. For example, the PubMed search term 
‘hyperchloremia’ generates 181 citations while 
‘hypernatremia’ and ‘hypercalcemia’ generate 2,481 and 
15,518 citations, respectively [2]. It is therefore little 
surprise that chloride is sometimes referred to as the 
forgotten electrolyte [3].
Progress in our understanding of acid–base and 
chloride channel physiology, however, challenges the 
notion that neglecting chloride is justiﬁ ed. Th is progress 
can be traced to more than 100 years ago with the 
observation of a poisonous eﬀ ect of sodium chloride 
solutions on nerve muscle preparation [4], followed by 
recognition of metabolic acidosis after saline infusion in 
the 1920s [5], and the concept of hyperchloraemic 
acidosis [6,7]. In the 1990s, hyperchloraemic acidosis 
became more thoroughly studied [8-15] as the physico-
chemical approach (Stewart approach) to acid–base 
analysis [16,17] began to receive wider acceptance. 
Within the Stewart approach, chloride is the dominant 
negative strong ion in plasma and a key contributor to 
the strong ion diﬀ erence (SID), one of the three 
independent variables that determine the hydrogen ion 
concentration. Hyperchloraemia was thus ﬁ nally seen as 
important for the pathogenesis of metabolic acidosis. 
Th is change in perception may be particularly relevant to 
intensivists, given that hyperchloraemia appears rela-
tively common in intensive care unit (ICU) patients [18]. 
At the same time, our knowledge of chloride channels 
has increased in the past decade with new discoveries of 
their crystal structures, physiological roles and their 
association with human diseases [19-21].
All of these changes in attitude and knowledge support 
the argument that the role of chloride in the ICU 
deserves more attention. In the present review, therefore, 
we wish to focus on the following ﬁ ve aspects: the funda-
mentals of chloride distribution and measurement, an 
outline of Stewart’s physicochemical approach and the 
signiﬁ cance of chloride as a strong ion, chloride’s roles 
through review of its channels and chloride regulation by 
the gut and kidney, chloride manipulation in the ICU and 
potential eﬀ ects of disorders of chloraemia in the 
critically ill, and the implications of all the above on 
current critical care practice and research.
Chloride distribution and measurement
Th e main source of chloride is dietary sodium chloride, 
intake of which is 7.8 to 11.8 g/day for adult men and 
5.8 to 7.8 g/day for adult women in the United States [22] – 
equivalent to 133 to 202  mmol and 99 to 133  mmol 
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chloride, respectively (chloride molar mass, 35.5 g/mol). 
Th is intake approximates to administration of 0.5 to 
1.3 litres per day of 0.9% saline (chloride, 154 mmol/l).
Th e chloride distribution in the three major body ﬂ uid 
compartments – plasma, interstitial ﬂ uid (ISF) and intra-
cellular ﬂ uid – is shown in Figure 1. Chloride is the most 
abundant anion in plasma and ISF, the two compart-
ments that make up extracellular ﬂ uid. Its concentrations 
in these two compartments diﬀ er slightly as a result of 
capillary impermeability to proteins, especially albumin. 
Th e asymmetric distribution of anionic proteins 
between plasma and ISF results in the Gibbs–Donnan 
eﬀ ect, with the ISF chloride concentration 5 to 10% 
greater than in plasma [23]. Most cells have intracellular 
concentrations of about 10  mmol/l [23], but the range 
varies widely from 2  mmol/l in skeletal muscle to 
90 mmol/l in erythrocytes [24].
It is important for clinicians to recognize that the 
measured plasma chloride concentration may diﬀ er 
between assays. With paired samples, the mean diﬀ er-
ence (bias) in plasma chloride concentration between 
central laboratory and point-of-care assays can be 
1.0 mmol/l (95% limits of agreement, –6.4 to 4.6 mmol/l) 
[25]. While decreased plasma albumin contributes to 
diﬀ erences in sodium assays, however, albumin changes 
have little eﬀ ect on chloride assays [26]. Further, while 
the reference range for central laboratory assays is often 
quoted as 97 to 107  mmol/l, some machines used in 
central laboratories have a reference range of 100 to 
110 mmol/l. Using paired samples (unpublished results), 
when our central laboratory changed from a Hitachi to a 
Beckman machine, we found a bias in plasma chloride of 
2.0 mmol/l (95% limits of agreement, –1.7 to 5.6 mmol/l). 
While these diﬀ erences are important in assessing 
chloride alone, they will also aﬀ ect derived variables 
including the anion gap [26], the corrected anion gap 
[27], the strong ion gap [28], and the sodium chloride 
diﬀ erence [29].
Chloride and the Stewart approach
Th e surge in the number of studies on hyperchloraemic 
acidosis coincided with the emergence of the Stewart 
physicochemical approach, with many comparisons of 
0.9% saline and colloids suspended in saline solutions 
with more balanced, lower chloride, intravenous solu-
tions (Tables 1 and 2). Compared with lactated Ringer’s 
solution in patients undergoing major gynaecological 
surgery, infusion of 30 ml/kg/hour of 0.9% saline caused a 
signiﬁ cant acidosis within 2  hours [9]. Th is ﬁ nding, 
coupled with higher chloride measurement in the saline 
group, was replicated in a number of other studies 
[10,12,14,15,30]. Signiﬁ cant negative correlation between 
hyperchloraemia and base excess was further shown in 
patients undergoing surgery for more than 4 hours [10] 
and in an audit of ICU patients [18].
An understanding of Stewart’s approach may help to 
understand how chloride might aﬀ ect the hydrogen ion 
concentration [H+] [16,17]. Th rough quantitative analysis 
that satisﬁ es the principles of electroneutrality, dissocia-
tion equilibria and conservation of mass, this approach 
argues that determination of [H+] depends on three 
independent variables: the SID, the partial pressure of 
carbon dioxide, and the total weak acid concentration. A 
change in any of these three variables, and not in 
Figure 1. Chloride distribution in the major body fl uid compartments.
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bicarbonate, will change the acid–base balance. 
Bicarbonate becomes a marker and not a mechanism, a 
major diﬀ erence between the Stewart approach and the 
traditional Henderson–Hasselbalch approach.
In the traditional approach, bicarbonate independently 
determines pH as reﬂ ected by the Henderson–Hassel-
balch equation:
pH = pK + log ([HCO3–] / [CO2])
Under the Stewart approach, however, bicarbonate is 
just one of the various dependent ions. Whether the 
Stewart approach more truly reﬂ ects the biochemical 
events at work during acid–base disorders remains 
controversial. However, its practical utility has been 
repeatedly shown [11,31].
Together with other completely dissociated strong ions, 
chloride determines the SID:
SID = (Na + K + Mg + Ca) – (Cl + lactate)
Quantitatively, a change in the strong ion composition 
leading to lower SID will increase [H+] while an increase 
in SID will decrease [H+]. Hyperchloraemic acidosis 
there fore causes acidosis by decreasing SID and not 
through hyperchloraemia alone. Th is notion is supported 
by data demonstrating a stronger association between 
SID and bicarbonate than that between chloride and 
bicarbonate [31].
Hyperchloraemic acidosis is now increasingly des-
cribed in terms of its SID nature, including the contri-
bution of the strong ion gap or unmeasured anions 
Table 1. Electrolyte composition of commonly used crystalloids
   Concentration (mmol/l)
 Plasma 0.9% NaCl Hartmann’s Plasma-Lyte 148® Sterofundin®
Sodium 140 154 131 140 140
Potassium 5 0 5 5 4
Chloride 100 154 111 98 127
Calcium 2.2 0 2 0 2.5
Magnesium 1 0 1 1.5 1
Bicarbonate 24 0 0 0 0
Lactate 1 0 29 0 0
Acetate 0 0 0 27 24
Gluconate 0 0 0 23 0
Maleate 0 0 0 0 5
Plasma-Lyte 148® from Baxter International (Deerfi eld, IL, USA). Sterofundin® from B Braun (Melsungen, Germany).
Table 2. Electrolyte composition of commonly used colloids
 Concentration (mmol/l)
    Voluven®
    (HES 6% 130/0.4)/  
    Venofundin® Hextend® Tetraspan®
 Plasma Gelofusine® Albumex®4 (HES 6% 130/0.42) (HES 6% 130/0.4) (HES 6% 130/0.42)
Sodium 140 154 140 154 143 140
Potassium 5 0 0 0 3 4.0
Chloride 100 125 128 154 124 118
Calcium 2.2 0 0 0 2.5 2.5
Magnesium 1 0 0 0 0.5 1.0
Bicarbonate 24 0 0 0 0 0
Lactate 1 0 0 0 28 0
Acetate 0 0 0 0 0 24
Malate 0 0 0 0 0 5
Octanoate 0 0 6.4 0 0 0
HES, hydroxyethyl starch. Gelofusine®, Venofundin® and Tetraspan® from B Braun (Melsungen, Germany). Albumex®4 from CSL Limited (Broadmeadows, Victoria, 
Australia). Voluven® from Fresenius-Kabi (Bad Homburg, Germany). Hextend® from BioTime Inc. (Berkeley, CA, USA).
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[32,33]. A detailed explanation of these concepts is 
beyond the scope of the present review.
At the other end of the spectrum, alkalosis may thus 
occur with both hypochloraemia and hyperchloraemia, 
with the latter occurring in the presence of greater 
hypernatraemia (greater SID) [34]. Th is again highlights 
the importance of relative rather than absolute chloraemia. 
In a study of patients with chronic obstructive pulmonary 
disease, subjects were found to have hypochloraemia 
without signiﬁ cant changes in plasma sodium, resulting 
in a higher SID and subsequent alkalosis [35]. Th is 
interestingly concurs with an animal study showing 
increased renal chloride excretion during hypo chloraemia 
of respiratory acidosis [36].
Chloride channels
For years, knowledge of chloride channels lagged behind 
the better known sodium, potassium and calcium 
channels [19]. Several milestones in the ﬁ eld of ion 
channels – such as cloning of the cystic ﬁ brosis trans-
membrane regulator in 1989, cloning of the ﬁ rst voltage-
gated chloride channel in 1990 and, more recently, 
discovery of the crystal structure of chloride channels 
[19-21] – have altered this scenario. Th ese anion channels 
are no longer merely unimportant leaks associated with 
cation channels in the excitable cells [37].
Examples of the diﬀ erent subtypes of these channels, 
categorised based on their diﬀ erent regulations and roles, 
are presented in Table 3. Of these subtypes, the cystic 
ﬁ brosis transmembrane conductance regulator and the 
ligand-gated chloride channels, activated by GABAA and 
glycine, are probably best known to ICU clinicians. Th e 
other subtypes are, nevertheless, no less important. 
Voltage-gated chloride channels come from nine diﬀ erent 
genes with a unique dimeric, double-pore (double-
barrelled) structure [20,21]. Th e structure discovery and 
further exploration of their molecular mechanisms are 
seen as frontiers towards greater application of chloride 
channel manipulation in medicine. Recent insights into 
these voltage-gated chloride channels have already showed 
their signiﬁ cant neurological [38,39] and gastro intestinal 
[40] connections. Calcium-activated chloride channels, on 
the other hand, are found in various cell types, including 
epithelial cells, neurons, cardiac cells, smooth muscles and 
blood cells [21]. Th ey are activated by cytoplasmic calcium 
elevation following a wide range of stimuli, which include 
cholinergic activation of glandular secretory epithelium 
and pain in the dorsal root ganglia neurons [37]. Finally, 
volume-sensitive chloride channels are an essential 
element of cell volume regulation. Expo sure to hypotonic 
media stimulates chloride ion eﬄ  ux through these 
channels, leading to equilibrium with extracellular tonicity; 
restoring the cell volume in the process [21]. Th is cell-
volume decrease is now believed to have a role in apoptotic 
cell death [41], a phenomenon of interest in sepsis [42].
Chloride regulation by the gut and kidney
Gastrointestinal secretions are rich in chloride, with 
gastric secretions the predominant source. In the stomach, 
chloride secreted by apical chloride channels in parietal 
cells will match hydrogen ions released by the H+/K+-
ATPase antiporter pumps (proton pumps), forming 
hydrochloric acid. Basal output of this acid is in the range 
0 to 11 mmol/hour, increasing to 10 to 63 mmol/hour with 
meals [43]. Th is load of acid, and thus chloride, is regulated 
by synergistic activities of histamine, gastrin and 
acetylcholine.
Chloride is also the main electrolyte driving ﬂ uid secre-
tion throughout the intestinal epithelium. Para cellular 
movement of sodium that accompanies transepithelial 
chloride secretion results in luminal sodium chloride, 
which forms the osmotic pressure for water movement 
with secretions of 8  l/day [44], which are largely 
reabsorbed throughout the intestinal tract.
Chloride is primarily excreted by the kidney. An 
average of 19,440  mmol is ﬁ ltered through the kidneys 
Table 3. Examples of chloride channels
Channel Mechanism of regulation Physiological role
CFTR channels Cyclic AMP-dependent phosphorylation Cl– secretion in airways, submucosal glands, pancreas, intestine 
  and testis; Cl– absorption in sweat glands
CIC-1 channels Depolarization Cl– conductance in skeletal muscle; repolarization after action 
  potential
CIC-2 channels Hyperpolarization and cell swelling Cl– homeostasis in neurons
Calcium-activated chloride channels Cystosolic Ca2+ Cl– transport in retinal pigment epithelium; Cl– secretion in 
  epithelia, neurons, cardiac muscles and erythrocytes; smooth 
  muscle contraction
GABAA channels GABAA Inhibition of synaptic transmission in the brain
Glycine channels Glycine, β-alanine and taurine Inhibition of synaptic transmission in the spinal cord
Volume-sensitive chloride channels Cell volume changes Restoration of cell volume
CFTR, cystic fi brosis transmembrane conductance regulator; CIC, voltage-gated chloride channel; GABA, γ-aminobutyric acid.
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every day, with 99.1% being reabsorbed, leaving only 
180 mmol excreted per day [45]. Most of the reabsorption 
occurs in the proximal tubule, by passive reabsorption, 
ion conductance or active coupled transport with other 
ions [46]. Chloride reabsorption involves members of the 
solute carrier (SLC) gene families SLC26 and SLC24. 
Th ese two gene families are expressed in various parts of 
the kidney, particularly in key components of renal acid–
base regulation; that is, renal proximal tubules and 
intercalated cells of distal nephron. Th e intercalated cells 
are further diﬀ erentiated into type A (alpha) cells that 
excrete protons and type B (beta) cells that secrete 
bicarbonate and reabsorb chloride [47]. Th e transport 
activities of the two SLC families underline the role of 
chloride in renal acid–base regulation.
Th e SLC26 family are primarily chloride-anion 
exchangers; exchanging sulphate, iodide, formate, oxalate, 
hydroxyl ion and bicarbonate anions [47]. Th ey include 
SLC26A6 in the proximal tubule that mediates apical 
chloride-anion exchange, and SLC26A4 (pendrin) in the 
distal nephron that mediates chloride-anion exchange 
across the luminal membrane of type B intercalated cells.
Th e SLC4 solute carriers, on the other hand, pre-
dominantly function as chloride-bicarbonate and anion 
exchangers and sodium-bicarbonate co-trans porters (NBC). 
Examples are SLC4A1 (also known as AE1), which medi-
ates chloride-bicarbonate exchange in the baso lateral 
membrane of type A intercalated cells (exchange of 
chloride into intercalated cells and bi carbo nate into 
plasma), and SLC4A4 (also known as NBC1), which 
mediates sodium-bicarbonate co-trans port in renal 
proxi mal tubule cells [46,48].
Th ese renal chloride carriers are key components of 
suggested models for physicochemical renal acid–base 
regulation [46]. Figure 2 shows an example of such regu-
la tion across proximal tubule cells. Physicochemical 
modelling of distal renal tubular acidosis from mutation 
of SLC4A1 (AE1) and proximal renal tubular acidosis 
from mutation of SLC4A4 (NBC1) [49] has also conso li-
dated the argument for the Stewart approach. Th is renal 
tubular acidosis modelling focuses on renal net hand ling 
of Na+, K+ and Cl–, the SID constituents, which means 
that chloride movement is no longer secondary to 
bicarbonate changes. In another physicochemical view-
point, a departure from the conventional explanation of 
ammonium ion NH4+ as a carrier of H+ has been 
proposed [50]. NH4+ should instead be seen as a weak 
cation that, by co-excretion with chloride, allows loss of 
chloride without sodium or potassium.
Disorders of chloraemia and manipulation of 
chloride in the ICU
Hyperchloraemia or hypochloraemia, resulting from 
disease processes or clinical manipulations, is common in 
Figure 2. Integration of proximal convoluted tubule chloride transport mechanisms with strong ion diff erence and partial pressure. Chloride 
is reabsorbed from passive paracellular transport, conductance and active coupled transport at both apical and basolateral membranes. The strong 
ion diff erence (SID) in the plasma, together with the partial pressure of carbon dioxide (PCO2), regulates these transport activities and determines the 
hydrogen ion concentration. KCC, K+Cl– co-transporter; NHE, Na+H+ exchanger; SLC26A6, solute carrier 26A6; SLC4A4, solute carrier 4A4.
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the ICU (see Tables 4 and 5), and should always be seen in 
relation to sodium. Hyperchloraemia with hyper natraemia, 
or hypochloraemia with hyponatraemia, will not change 
the SID and thus will not aﬀ ect the acid–base balance.
Intravenous administration of chloride-rich ﬂ uids is 
probably the most common and modiﬁ able cause of 
hyper chloraemia in the ICU. Th e chloride content of 
these ﬂ uids, from 0.9% NaCl (saline) to the various 
colloids suspended in saline (Tables 1 and 2), is supra-
physiologic [51], with signiﬁ cant hyperchloraemia follow-
ing the administration of such ﬂ uids in volunteers [13,52], 
intraoperatively [9,10,12,14,15,30] or as cardio pulmonary 
bypass prime ﬂ uid [11].
While saline was a life-saving measure when ﬁ rst 
introduced during the cholera pandemic of Europe in the 
1830s [53], it is to be noted that the saline used then was 
of a diﬀ erent composition. A reconstitution of the 
Th omas Latta solution revealed a sodium concentration 
of 134  mmol/l, chloride 118  mmol/l and bicarbonate 
16  mmol/l. Th e historical or scientiﬁ c basis of the 
present-day 0.9% composition of saline remains a 
mystery, even when traced to those cholera pandemic 
days that marked the beginning of the intravenous ﬂ uid 
technique and its various solutions [54]. On the other 
hand, there appears to be common lack of basic 
knowledge for optimal ﬂ uid and electrolyte prescription. 
Intravenous ﬂ uid and electrolyte prescriptions in 
postoperative surgical patients vary widely, with 0.9% 
saline being most common, and show poor correlation 
between serum electrolyte values and the amounts of 
electrolytes prescribed [55]. Moreover, less than one-half 
of prescribers in 25 diﬀ erent surgical units were aware of 
the sodium content of 0.9% saline [56]. Chloride-rich 
ﬂ uids result in acidosis and evidence from animal studies, 
particularly in sepsis, point to a possible association with 
negative outcomes.
Chloride and resuscitation of sepsis
Fluid resuscitation is a mainstay for the treatment of 
severe sepsis. Th e recognition of hyperchloraemic strong 
ion acidosis has led to the reconsideration of the impact 
of intravenous ﬂ uid contents in septic patients.
In anaesthetized dogs infused with endotoxin, high 
chloride saline infusion given to maintain mean arterial 
pressure >80  mmHg increased serum chloride and 
accounted for 42% of the total acid load [57], signiﬁ cantly 
greater than the contribution by lactate. When com par-
ing saline resuscitation with Hextend® (hydroxyethyl 
starch (HES) in balanced solution; BioTime Inc., Berkeley, 
CA, USA) in a rat model of septic shock, investigators 
reported signiﬁ cantly lower standard base excess and SID 
and a lower mean survival time with saline [58].
In an animal study of the eﬀ ects of hyperchloraemic 
acidosis from saline, the degree of systemic hypotension 
correlated signiﬁ cantly with the increase in plasma 
chloride levels [59], a stronger correlation than with pH. 
A signiﬁ cant increase was also seen in plasma nitrite 
levels in the saline group; in cell cultures, however, hyper-
chloraemic acidosis was found to be proinﬂ ammatory, 
inducing nitric oxide release, increased IL-6:IL-10 ratios 
and increased NF-κB DNA binding [60]. In a second 
Table 4. Conditions associated with hypochloraemia in the 
intensive care unit
Chloride loss
 Diuretic therapy
 Signifi cant gastric drainage
 Vomiting
 Chronic respiratory acidosis
Water gain in excess of chloride
 Congestive cardiac failure
 Syndrome of inappropriate ADH secretion
 Excessive infusion of hypotonic solutions
Table 5. Conditions associated with hyperchloraemia in 
the intensive care unit
Chloride infusion
 Administration of chloride-rich fl uids 
 Total parenteral nutrition
Pure water loss
 Skin losses
 Fever
 Hypermetabolic states
 Renal losses
 Central diabetes insipidus
 Nephrogenic diabetes insipidus
Water loss in excess of chloride loss
 Extrarenal loss
 Diarrhoea
 Burns
 Renal loss
 Osmotic diuresis
 Post-obstructive diuresis
 Intrinsic renal disease
Defi nite or relative increase in tubular chloride reabsorption
 Renal tubular acidosis
 Recovery of diabetic ketoacidosis
 Early renal failure 
 Acetazolamide
 Ureteral diversion procedures
 Post hypocapnia
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animal study, after controlling for hypotension, there was 
a signiﬁ cant increase in cytokines with hyperchloraemic 
acidosis – greater increases were seen with more severe 
acidosis [61].
Th erefore it would seem prudent to avoid chloride-rich 
ﬂ uids in sepsis despite controversy on whether acidosis 
results in physiological injury or is just a side eﬀ ect of 
illness [62]. At present, the best evidence for acidosis-
induced organ injury is mainly from animal studies [63,64] – 
thus making any speciﬁ c recommendation diﬃ  cult.
Hyperchloraemia and renal function
Animal studies oﬀ er insight into the role of chloride in 
regulating renal blood ﬂ ow. In denervated dog kidneys, 
intrarenal infusion of chloride-containing solutions 
produced renal vasoconstriction and a fall in the glome-
rular ﬁ ltration rate [65]. Th is observation was speciﬁ c for 
renal vessels, and the investigators proposed tubular 
chloride reabsorption as a key initiating step, based on 
similarities with the tubuloglomerular feedback mecha-
nism, also initiated by chloride reabsorption [66]. Th is 
tubuloglomerular feedback is a regulation of the 
glomerular ﬁ ltration rate, which begins with chloride 
detection at the macula densa and ends with mesangial 
contraction reducing the glomerular ﬁ ltration rate. 
Increased chloride re-absorption through a Na/K/2Cl 
transporter activates the release of ATP for mesangial 
contraction [67]. In another animal study, the same group 
found that thromboxane may mediate chloride-induced 
vasoconstriction [68]. Another possible explanation for 
the phenomenon of hyperchloraemic renal vasocon stric-
tion is the eﬀ ect of chloride on renal responsiveness to 
vasoconstrictor agents. A study of the isolated rat kidney 
showed that continuous perfusion with high chloride 
progressively increased renal vascular responsiveness to 
angiotensin II [69]. A more comprehensive understanding 
of the vasoconstriction mechanisms, including probable 
interaction between chloride and other ions like calcium, 
could be on the horizon given the recent progress in 
chloride channels mentioned earlier.
Studies on human volunteers and patients support the 
above observations. A longer time to ﬁ rst micturition 
was observed with saline compared with a lactated 
solution in a crossover trial with human volunteers [70]. 
Th is observation was replicated in another human volun-
teer study, also with greater diuresis and natriuresis in 
the lactated solution group [52]. While the shorter time 
to micturition and greater diuresis could be attributed to 
the lower osmolality of the lactated solution causing 
decreased antidiuretic hormone secretion, the greater 
natriuresis suggests a speciﬁ c chloride eﬀ ect on the 
glomerular ﬁ ltration rate.
Of further interest to ICU practice is the comparison of 
high-chloride ﬂ uids and low-chloride ﬂ uids during 
surgery. In older patients undergoing major surgery, a 
lower chloride load from a lactated solution or 6% heta-
starch in balanced solution (Hextend®) again led to 
greater urine output compared with 0.9% saline and with 
6% hetastarch in 0.9% saline [14]. A comparable study in 
older cardiac surgery patients revealed that the lower 
chloride group treated with balanced 6% HES 130/0.42 
plus a balanced crystalloid solution had signiﬁ cantly 
lower urinary concentrations of kidney-speciﬁ c markers 
of injury – namely glutathione transferase alpha and neu-
tro phil gelatinase-associated lipocalin – when measured 
up to the second postoperative day in the ICU [71].
In patients with renal dysfunction, many believe the 
risk of hyperkalaemia is greater with potassium-contain-
ing ﬂ uids like lactated solutions, thus leading to 
signiﬁ cantly higher use of 0.9% saline [72]. In contra-
diction to this paradigm, a randomized double-blind trial 
comparing lactated Ringer’s solution and 0.9% saline 
during renal transplantation revealed a higher incidence 
of hyperkalaemia in the 0.9% saline group instead of in 
the lactated Ringer’s solution group. Th e incidence of 
metabolic acidosis was also higher in the 0.9% saline 
group [73]. Th e authors suggested that hyperkalaemia 
was secondary to extracellular potassium shift due to 
hyperchloraemic (low-SID) acidosis.
Chloride and splanchnic perfusion
Th e above crossover trial comparing 0.9% saline with the 
lactated Ringer’s solution in human volunteers also found 
a higher incidence of abdominal discomfort with saline 
[70]. Th is raised questions about splanchnic perfusion. In a 
study of older patients undergoing major surgery, the 
saline group had a higher postoperative gastric tono metric 
carbon dioxide gap, suggesting reduced gastric mucosal 
perfusion [14]. Th is study, although not powered to show a 
diﬀ erence, also showed a signiﬁ cant trend towards 
increased nausea and vomiting in the saline group. While 
chloride’s link to this phenomenon is unclear, it is 
interesting to note that a report of ammonium chloride 
poisoning referred to similar signs of nausea, vomiting and 
abdominal pain [74]. Animal studies, meanwhile, have 
demonstrated acidosis-induced intestinal injury [64] and 
impaired gastric-pyloric motility [75]. Th ese ﬁ ndings 
warrant further investigation to deﬁ ne the role of chloride 
in the modulation of splanchnic perfusion.
Chloride and haemostasis
In a swine model of massive haemorrhage [76] comparing 
resuscitation with 0.9% saline, Ringer’s lactate, Plasmalyte 
A and Plasmalyte R, investigators found that – apart from 
a signiﬁ cant decrease in acidosis with Ringer’s lactate, 
Plasmalyte A and Plasmalyte R – Ringer’s lactate also 
achieved a trend towards a higher survival rate. A decade 
later, in a rat model of massive haemorrhage, resusci tation 
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with red blood cells and Ringer’s lactate solution 
produced a signiﬁ cantly better acid–base balance and 
signiﬁ cantly greater 2-week survival than resuscitation 
with red blood cells and 0.9% saline [77]. Th e hyper-
chloraemic acidosis seen with 0.9% saline resuscitation 
has also been highlighted as an easily preventable iatro-
genic cause of acidosis in trauma resuscitation [78].
Hyperchloraemic acidosis has also been suggested as 
part of the explanation for increased blood loss, increased 
requirement for blood and blood products, and 
coagulation abnormalities in patients receiving 0.9% 
saline or HES suspended in saline [15,79,80]. In a rando-
mized trial comparing Hextend® (a 6% HES in a balanced 
solution) with 6% HES in saline, trends toward less 
bleeding were seen in the Hextend® group. Th e HES in 
saline group further showed signiﬁ cant prolongation of 
time to onset of clot formation on thromboelastography, 
an eﬀ ect not seen in the Hextend® group [79]. Another 
randomized trial comparing 0.9% saline against lactated 
Ringer’s solution for patients undergoing abdominal 
aortic aneur ysm demonstrated a similar pattern. Th e 
saline group received signiﬁ cantly more blood products 
and had a trend towards increased blood loss [15]. In 
another comparison of 6% HES in balanced vehicle 
against 6% HES in saline during major surgery, a hypo-
coagulable state (conﬁ rmed by signiﬁ cantly abnormal 
thrombo elasto graphy) was seen in HES in saline [80]. 
Apart from its high chloride concentration, the lack of 
calcium in saline is another explanation for saline’s worse 
haemostatic proﬁ le as shown in these trials.
Th ere have also been a number of experimental studies 
on healthy volunteers predominantly looking at the 
diﬀ erence between HES in saline and HES in balanced 
solutions [81-83]. All studies used thromboelastography 
to assess coagulation, and one study used whole blood 
aggregometry to assess platelet function. A similar trend 
toward hypocoagulation with HES in saline was seen. 
Haemodilution with HES in saline also resulted in 
reduced aggregometry. While HES itself is known to 
aﬀ ect coagulation and thromboelastography, recent 
changes to its physicochemical characteristics, especially 
molar substitution, has minimized this eﬀ ect. Th e solvent 
and its electrolyte composition might thus have contri-
buted to hypocoagulability.
Chloride in the ICU: the research agenda
Th e growing body of knowledge presented above 
highlights the need to re-evaluate our perception of 
chloride in critical care. Clinically, there is a need to re-
evaluate our intravenous ﬂ uid practice, the patients’ main 
source of external chloride. Th e evidence that the choice of 
ﬂ uids will aﬀ ect the acid–base balance and could cause a 
host of other potentially undesirable physiological altera-
tions, as described above, is diﬃ  cult to ignore.
More importantly, all of this preliminary evidence leads 
to a number of research questions that are pertinent to 
chloride and the care of ICU patients. How common is 
hyperchloraemia in the ICU? Is hyperchloraemia an 
independent predictor of death or other adverse out-
comes? Or does hyperchloraemia only matter when asso-
cia ted with SID changes or acidaemia? Can the elimina-
tion of chloride-rich ﬂ uids lead to clinical beneﬁ ts? We 
consider these to be questions that need urgent attention 
given the millions of litres of saline and the millions of 
millimoles of excess chloride administered to patients 
worldwide every day.
Conclusions
Chloride has been forgotten for too long. Better know-
ledge of its molecular functions, driven by new ﬁ ndings 
of the structure, molecular biology and physiology of its 
channels, and better understanding of the clinical eﬀ ects 
of chloride loading, indicate that alterations in the 
chloride balance and chloraemia, both absolute and 
relative to natraemia, can alter the acid–base status, cell 
biology, renal function and haemostasis. Th e clinical 
consequences of these biological and physiological 
alterations remain unclear. Th e observation that most of 
these alterations appear to have negative implications 
and the knowledge that high-chloride ﬂ uids are adminis-
tered to large numbers of patients worldwide, however, 
suggest the need to conduct formal investigations into 
the epidemiology and outcome implications of disorders 
of chloride balance and chloride concentration.
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